Your Article Summary
Using Thrombophilia Testing to Determine Anticoagulation Duration in Pediatric Thrombosis is not Cost-Effective
The Journal of Pediatrics, 07/01/09
O'Brien SH et al. - Universal thrombophilia testing after a first episode of thrombosis is not cost-effective when used solely to determine anticoagulation duration. Therefore, a full panel of thrombophilia studies does not need to be an automatic response at the time of any deep venous thrombosis diagnoses.
Related Articles
Clotting, Immune System, and Venous Thrombosis in Lung Adenocarcinoma Patients: A Prospective Study
Cancer Investigation, 11/18/09
Relevance Score: 89%
C-Reactive Protein and the Risk of Stent Thrombosis and Cardiovascular Events After Drug-Eluting Stent Implantation
Circulation, 11/04/09
Relevance Score: 88%
Lateral Sinus Thrombosis in the Pediatric Population: Multiple Presentations for a Potentially Lethal Disease
Pediatric Emergency Care, 10/21/09
Relevance Score: 88%
Cerebral Venous Thrombosis: Diagnostic Accuracy of Combined, Dynamic and Static, Contrast-Enhanced 4D MR Venography
American Journal of Neuroradiology, 11/13/09
Relevance Score: 87%
Scapular Abscess, Septic Emboli, and Deep Vein Thrombosis in a Healthy Child Due to Community-Acquired Methicillin-Resistant Staphylococcus aureus: Case Report
Pediatric Emergency Care, 10/29/09
Relevance Score: 87%
Today in Pediatrics...keeping you current
Receive free subspecialty "5-minute updates" via email
Rural children referred for conduct problems: evaluation of a collaborative program
The Australian Journal of Primary Health, 12/04/09
Skin-to-Skin Contact and/or Oral 25% Dextrose for Procedural Pain Relief for Term Newborn Infants
Pediatrics, 12/04/09
Research around practice partnerships: an example of building partnerships to address overweight and obesity in children
The Australian Journal of Primary Health, 12/04/09

See Latest Articles